During and after an exacerbation, mental recovery involves taking care of both your physical and mental health. Resting, ...

A recent trial showed that nicotinamide riboside supplementation might reduce airway inflammation in patients with COPD who ...

In the treatment of COPD exacerbations, systemic corticosteroids improve airflow limitations, decrease treatment failure rates, decrease the risk of relapse, and may improve symptoms and decrease ...

Share on Pinterest The GOLD COPD grading system uses symptoms and exacerbations to grade the severity of COPD. This helps your provider determine which medications to use to help control COPD.

“Patients with mild-to-moderate COPD who have low exercise tolerance are likely to experience poor respiratory health outcomes,” the investigators concluded. “Exercise tolerance may be considered one ...

Some people have asthma and COPD at the same time. If you have symptoms of both, your doctor may call it asthma-COPD overlap. If you’ve been diagnosed with COPD, you might be wondering what ...

In COPD patients, home monitoring has ... and blood oxygen levels to help detect worsening respiratory symptoms or an oncoming respiratory exacerbation. 12 Pedometer or accelerometer tracking ...

Chronic obstructive pulmonary disease (COPD) is an irreversible inflammatory disease of the lungs that makes it more difficult to breathe over time. The disease causes changes to the tissues inside ...

fuelled by strong take-up in patients who are prone to exacerbations – the sudden flare-ups in symptoms that signpost the relentless progression of COPD. Zaccardelli said the prescribing and ...

When lung function is more severely impaired, the effects of smoking cessation on symptoms and on the subsequent decline in FEV 1 are not known. The prevalence of smoking is greatest and cessation ...

The 5th edition of Manipal Hospital Old Airport Road's flagship workshop series, Handling Unexpected Emergencies (HUE), ...

GSK plc GSK recently announced that EMA has accepted the regulatory filing seeking approval for its IL-5 inhibitor ...